Windlas Biotech Ltd

NSE: WINDLAS · BSE: 543329 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹1,028.00
Market cap: ₹2,158 Cr
Revenue (annual): ₹904.1 Cr
Net profit (annual): ₹66.44 Cr
P/E (TTM): 32.5×Sector 47.4×
Promoter holding: 63.31%+1.41% QoQ
FII holding: 2.04%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

30 Apr 2026 13:06 IST BSE

Windlas Biotech Debt & Borrowing

Windlas Biotech Limited confirmed it does not fall under the 'Large Corporate' category for the financial year 2026-27 as per SEBI criteria. The company reported zero outstanding borrowings as of March 31, 2026, and maintains an ICRA A+ credit rating.

Read the filing ↗